ID   UBE2W_HUMAN             Reviewed;         151 AA.
AC   Q96B02; B4DIV1; Q1XBE0; Q9H823; Q9HAG6; Q9NV07;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 W;
DE            EC=2.3.2.23 {ECO:0000269|PubMed:20061386};
DE   AltName: Full=E2 ubiquitin-conjugating enzyme W;
DE   AltName: Full=N-terminal E2 ubiquitin-conjugating enzyme;
DE            EC=2.3.2.25 {ECO:0000269|PubMed:23560854, ECO:0000269|PubMed:23696636};
DE   AltName: Full=N-terminus-conjugating E2;
DE   AltName: Full=Ubiquitin carrier protein W;
DE   AltName: Full=Ubiquitin-conjugating enzyme 16;
DE            Short=UBC-16;
DE   AltName: Full=Ubiquitin-protein ligase W;
GN   Name=UBE2W; Synonyms=UBC16;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF CYS-91.
RX   PubMed=16368532; DOI=10.2741/1899;
RA   Yin G., Ji C., Wu T., Shen Z., Xu X., Xie Y., Mao Y.;
RT   "Cloning, characterization and subcellular localization of a gene
RT   encoding a human Ubiquitin-conjugating enzyme (E2) homologous to the
RT   Arabidopsis thaliana UBC-16 gene product.";
RL   Front. Biosci. 11:1500-1507(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Embryo, Hippocampus, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH FANCL.
RX   PubMed=19111657; DOI=10.1016/j.molcel.2008.12.003;
RA   Alpi A.F., Pace P.E., Babu M.M., Patel K.J.;
RT   "Mechanistic insight into site-restricted monoubiquitination of FANCD2
RT   by Ube2t, FANCL, and FANCI.";
RL   Mol. Cell 32:767-777(2008).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20061386; DOI=10.1074/jbc.M109.089003;
RA   David Y., Ziv T., Admon A., Navon A.;
RT   "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to
RT   preferred lysines.";
RL   J. Biol. Chem. 285:8595-8604(2010).
RN   [9]
RP   FUNCTION.
RX   PubMed=21229326; DOI=10.1007/s10059-011-0015-9;
RA   Zhang Y., Zhou X., Zhao L., Li C., Zhu H., Xu L., Shan L., Liao X.,
RA   Guo Z., Huang P.;
RT   "UBE2W interacts with FANCL and regulates the monoubiquitination of
RT   Fanconi anemia protein FANCD2.";
RL   Mol. Cells 31:113-122(2011).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, UBIQUITINATION AT MET-1, AND SUBSTRATE
RP   SPECIFICITY.
RX   PubMed=23560854; DOI=10.1042/BJ20130244;
RA   Tatham M.H., Plechanovova A., Jaffray E.G., Salmen H., Hay R.T.;
RT   "Ube2W conjugates ubiquitin to alpha-amino groups of protein N-
RT   termini.";
RL   Biochem. J. 453:137-145(2013).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND MUTAGENESIS
RP   OF HIS-83.
RX   PubMed=23696636; DOI=10.1074/jbc.C113.477596;
RA   Scaglione K.M., Basrur V., Ashraf N.S., Konen J.R.,
RA   Elenitoba-Johnson K.S., Todi S.V., Paulson H.L.;
RT   "The ubiquitin-conjugating enzyme (E2) Ube2w ubiquitinates the N
RT   terminus of substrates.";
RL   J. Biol. Chem. 288:18784-18788(2013).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 1-117, AND SUBUNIT.
RX   PubMed=22496338; DOI=10.1074/mcp.O111.013706;
RA   Sheng Y., Hong J.H., Doherty R., Srikumar T., Shloush J.,
RA   Avvakumov G.V., Walker J.R., Xue S., Neculai D., Wan J.W., Kim S.K.,
RA   Arrowsmith C.H., Raught B., Dhe-Paganon S.;
RT   "A human ubiquitin conjugating enzyme (E2)-HECT E3 ligase structure-
RT   function screen.";
RL   Mol. Cell. Proteomics 11:329-341(2012).
CC   -!- FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its
CC       covalent attachment to other proteins. Catalyzes
CC       monoubiquitination. Involved in degradation of misfolded chaperone
CC       substrates by mediating monoubiquitination of STUB1/CHIP, leading
CC       to recruitment of ATXN3 to monoubiquitinated STUB1/CHIP, and
CC       restriction of the length of ubiquitin chain attached to
CC       STUB1/CHIP substrates by ATXN3. After UV irradiation, but not
CC       after mitomycin-C (MMC) treatment, acts as a specific E2
CC       ubiquitin-conjugating enzyme for the Fanconi anemia complex by
CC       associating with E3 ubiquitin-protein ligase FANCL and catalyzing
CC       monoubiquitination of FANCD2, a key step in the DNA damage
CC       pathway. In vitro catalyzes 'Lys-11'-linked polyubiquitination.
CC       Transfers ubiquitin in complex with RING/U-box type E3s that do
CC       not have active site cysteine residues to form thioester bonds
CC       with ubiquitin, and preferentially ubiquitinates the N-terminus of
CC       substrates, such as ATXN3, STUB1 and SUMO2.
CC       {ECO:0000269|PubMed:19111657, ECO:0000269|PubMed:20061386,
CC       ECO:0000269|PubMed:21229326, ECO:0000269|PubMed:23560854,
CC       ECO:0000269|PubMed:23696636}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388, ECO:0000269|PubMed:20061386}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [acceptor protein]-N-terminal-amino acid =
CC       [E1 ubiquitin-activating enzyme]-L-cysteine + N-terminal-
CC       ubiquitinyl-[acceptor protein]. {ECO:0000269|PubMed:23560854,
CC       ECO:0000269|PubMed:23696636}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Homodimer. Interacts with FANCL (Ref.7). Interacts with
CC       STUB1/CHIP (By similarity). {ECO:0000250|UniProtKB:Q8VDW4,
CC       ECO:0000269|PubMed:19111657}.
CC   -!- INTERACTION:
CC       Q9NX47:MARCH5; NbExp=4; IntAct=EBI-716589, EBI-2341610;
CC       O43586:PSTPIP1; NbExp=4; IntAct=EBI-716589, EBI-1050964;
CC       Q99942:RNF5; NbExp=4; IntAct=EBI-716589, EBI-348482;
CC       Q9HAT0:ROPN1; NbExp=3; IntAct=EBI-716589, EBI-1378139;
CC       Q8N6Y0:USHBP1; NbExp=3; IntAct=EBI-716589, EBI-739895;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16368532}.
CC       Note=In the nucleus, colocalizes with FANCL.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96B02-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96B02-2; Sequence=VSP_017943;
CC       Name=3;
CC         IsoId=Q96B02-3; Sequence=VSP_042974;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest expression in
CC       brain, liver, pancreas and heart. {ECO:0000269|PubMed:16368532}.
CC   -!- PTM: Ubiquitinated in vitro in the presence of FANCL (By
CC       similarity). Autoubiquitinated at Met-1.
CC       {ECO:0000250|UniProtKB:Q8VDW4, ECO:0000269|PubMed:23560854}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY948289; AAY24555.1; -; mRNA.
DR   EMBL; AK001873; BAA91954.1; -; mRNA.
DR   EMBL; AK021735; BAB13883.1; -; mRNA.
DR   EMBL; AK024050; BAB14800.1; -; mRNA.
DR   EMBL; AK295792; BAG58613.1; -; mRNA.
DR   EMBL; CR457275; CAG33556.1; -; mRNA.
DR   EMBL; CH471068; EAW87009.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW87011.1; -; Genomic_DNA.
DR   EMBL; AC022826; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016326; AAH16326.1; -; mRNA.
DR   CCDS; CCDS47874.2; -. [Q96B02-3]
DR   RefSeq; NP_001001481.2; NM_001001481.2.
DR   RefSeq; NP_001257944.1; NM_001271015.1.
DR   RefSeq; NP_060769.4; NM_018299.4. [Q96B02-3]
DR   UniGene; Hs.128841; -.
DR   PDB; 2A7L; X-ray; 1.82 A; A/B=1-117.
DR   PDB; 2MT6; NMR; -; A=1-151.
DR   PDBsum; 2A7L; -.
DR   PDBsum; 2MT6; -.
DR   ProteinModelPortal; Q96B02; -.
DR   SMR; Q96B02; -.
DR   BioGrid; 120572; 77.
DR   DIP; DIP-52724N; -.
DR   IntAct; Q96B02; 70.
DR   MINT; MINT-1428082; -.
DR   STRING; 9606.ENSP00000454445; -.
DR   iPTMnet; Q96B02; -.
DR   PhosphoSitePlus; Q96B02; -.
DR   DMDM; 74751754; -.
DR   MaxQB; Q96B02; -.
DR   PaxDb; Q96B02; -.
DR   PeptideAtlas; Q96B02; -.
DR   PRIDE; Q96B02; -.
DR   DNASU; 55284; -.
DR   Ensembl; ENST00000517608; ENSP00000428813; ENSG00000104343. [Q96B02-3]
DR   Ensembl; ENST00000602593; ENSP00000473561; ENSG00000104343. [Q96B02-1]
DR   GeneID; 55284; -.
DR   KEGG; hsa:55284; -.
DR   UCSC; uc003xzv.4; human. [Q96B02-1]
DR   CTD; 55284; -.
DR   GeneCards; UBE2W; -.
DR   HGNC; HGNC:25616; UBE2W.
DR   HPA; HPA045161; -.
DR   HPA; HPA073181; -.
DR   MIM; 614277; gene.
DR   neXtProt; NX_Q96B02; -.
DR   OpenTargets; ENSG00000104343; -.
DR   PharmGKB; PA142670657; -.
DR   eggNOG; KOG0427; Eukaryota.
DR   eggNOG; COG5078; LUCA.
DR   GeneTree; ENSGT00730000110565; -.
DR   HOGENOM; HOG000233453; -.
DR   HOVERGEN; HBG063308; -.
DR   InParanoid; Q96B02; -.
DR   KO; K10688; -.
DR   PhylomeDB; Q96B02; -.
DR   TreeFam; TF314582; -.
DR   BioCyc; MetaCyc:HS11901-MONOMER; -.
DR   BRENDA; 2.3.2.B6; 2681.
DR   BRENDA; 2.3.2.B7; 2681.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q96B02; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2W; human.
DR   EvolutionaryTrace; Q96B02; -.
DR   GenomeRNAi; 55284; -.
DR   PRO; PR:Q96B02; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000104343; -.
DR   CleanEx; HS_UBE2W; -.
DR   ExpressionAtlas; Q96B02; baseline and differential.
DR   Genevisible; Q96B02; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0071218; P:cellular response to misfolded protein; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   DNA damage; DNA repair; Nucleotide-binding; Nucleus;
KW   Reference proteome; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1    151       Ubiquitin-conjugating enzyme E2 W.
FT                                /FTId=PRO_0000232689.
FT   ACT_SITE     91     91       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00388}.
FT   CROSSLNK      1      1       Peptide (Met-Gly) (interchain with G-Cter
FT                                in ubiquitin).
FT                                {ECO:0000269|PubMed:23560854}.
FT   VAR_SEQ       1      1       M -> MLSPRGVTRARQLLPLRLWPRRSWGDGSIM (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042974.
FT   VAR_SEQ       5      5       Q -> QTTGRRVEVWFP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:16368532}.
FT                                /FTId=VSP_017943.
FT   MUTAGEN      83     83       H->N: Impaired substrate ubiquitination
FT                                of both Tau and ATXN3.
FT                                {ECO:0000269|PubMed:23696636}.
FT   MUTAGEN      91     91       C->A: Loss of predominant nuclear
FT                                localization.
FT                                {ECO:0000269|PubMed:16368532}.
FT   CONFLICT     26     26       N -> S (in Ref. 2; BAB13883).
FT                                {ECO:0000305}.
FT   CONFLICT     45     45       P -> S (in Ref. 2; BAA91954).
FT                                {ECO:0000305}.
FT   HELIX         6     17       {ECO:0000244|PDB:2A7L}.
FT   STRAND       23     28       {ECO:0000244|PDB:2MT6}.
FT   STRAND       35     42       {ECO:0000244|PDB:2A7L}.
FT   TURN         48     51       {ECO:0000244|PDB:2A7L}.
FT   STRAND       53     60       {ECO:0000244|PDB:2A7L}.
FT   TURN         62     66       {ECO:0000244|PDB:2A7L}.
FT   STRAND       70     76       {ECO:0000244|PDB:2A7L}.
FT   STRAND       88     90       {ECO:0000244|PDB:2MT6}.
FT   HELIX        93     95       {ECO:0000244|PDB:2A7L}.
FT   TURN         96     98       {ECO:0000244|PDB:2A7L}.
FT   HELIX       105    115       {ECO:0000244|PDB:2A7L}.
FT   HELIX       128    133       {ECO:0000244|PDB:2MT6}.
FT   HELIX       134    137       {ECO:0000244|PDB:2MT6}.
SQ   SEQUENCE   151 AA;  17331 MW;  276B585BBC4CEB71 CRC64;
     MASMQKRLQK ELLALQNDPP PGMTLNEKSV QNSITQWIVD MEGAPGTLYE GEKFQLLFKF
     SSRYPFDSPQ VMFTGENIPV HPHVYSNGHI CLSILTEDWS PALSVQSVCL SIISMLSSCK
     EKRRPPDNSF YVRTCNKNPK KTKWWYHDDT C
//
